Apeiron Investment Group Ltd. - Sep 30, 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
10%+ Owner
Signature
Apeiron Investment Group Ltd. By: /s/ Mario Frendo, Director
Stock symbol
ATAI
Transactions as of
Sep 30, 2025
Transactions value $
$0
Form type
4
Date filed
10/2/2025, 04:18 PM
Previous filing
Aug 18, 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Apeiron Investment Group Ltd. 10%+ Owner 66 & 67 BEATRICE, AMERY STREET, SILEMA, MALTA Apeiron Investment Group Ltd. By: /s/ Mario Frendo, Director 2025-10-02 0001845711
Angermayer Christian Director, 10%+ Owner 66 & 67 AMERY STREET, SILEMA, MALTA /s/ Christian Angermayer 2025-10-02 0001845872

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATAI Common Shares Conversion of derivative security +2.37M +4.64% 53.4M Sep 30, 2025 By Apeiron Investment Group Ltd. F1
holding ATAI Common Shares 1.8M Sep 30, 2025 By Apeiron Presight Capital Fund II, L.P.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Convertible Notes Conversion of derivative security -148K -100% 0 Sep 30, 2025 Common Shares 2.37M By Apeiron Investment Group Ltd. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The conversion price for the Convertible Notes is EUR 17.00 per note.
F2 The Convertible Notes were acquired in exchange for convertible notes issued by ATAI Life Sciences AG with substantially similar terms and economics.